The Caspase-3 and c-myc Expressions in Completely Resected Non-small Cell Lung Cancer and Its Prognostic Significance
![]() |
Cho, Deog-Gon
(Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, The Catholic University of Korea)
Cho, Kyu-Do (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, The Catholic University of Korea) Kang, Chul-Ung (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, The Catholic University of Korea) Jo, Min-Seop (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, The Catholic University of Korea) Yoo, Jin-Young (Department of Pathology, St. Vincent's Hospital, The Catholic University of Korea) Ahn, Myeong-Im (Department of Radiology, St. Vincent's Hospital, The Catholic University of Korea) Kim, Chi-Hong (Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea) Shim, Byoung-Yong (Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea) Kim, Sung-Whan (Department of Radiation Oncology, St. Vincent's Hospital, The Catholic University of Korea) Kim, Hoon-Kyo (Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea) |
1 | Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73: 2013-26. DOI ScienceOn |
2 | Estrov Z, Thall PF, Talpaz M, et al. Caspase-2 an caspase-3 protein levels as predictors of survival in acute myelogenous leukemia. Blood 1998;92;3090-7. PUBMED |
3 | Zajac-Kaye M. Myc oncogene: a key component in cell cyle regulation and its implication for lung cancer. Lung Cancer 2001;34(suppl 2):S43-6. DOI ScienceOn |
4 | Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9. DOI PUBMED ScienceOn |
5 | Kondo S, Tanaka Y, Kondo Y, et al. Retroviral transfer of CPP32 beta gene into malignant gliomas in vitro and in vivo. Cancer Res 1998;5:962-7. |
6 | Isobe N, Onodera H, Shimada Y, et al. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology 2004;66:201-9. DOI ScienceOn |
7 | Wyllie AH. Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 1993;67:205-8. DOI PUBMED ScienceOn |
8 | Yakut T, Egeli U, Gebitekin C. Investigaton of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique. Lung 2003;181:245-58. DOI ScienceOn |
9 | Jonges LE, Nagelkerke JF, Ensink NG, et al. Caspase-3 activity as a prognostic factor in cororectal carcinoma. Lab Invest 2001;81:681-8. DOI PUBMED ScienceOn |
10 | Rha SJ, Kwack MS. Microsatellite instability and p53, k-ras, c-myc oncoprotein expression in non-small cell lung carcinoma. Korean J Thorac Cardiovasc Surg 2000;33:60-7. |
11 | Hsia JY, Chen CY, Chen JT, et al. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. Eur J Sur Oncol 2003;29:44-8. DOI ScienceOn |
12 | Yoo JY, Kim CH, Song SH, et al. Expression of caspase-3 and c-myc in non-small cell lung cancer. Cancer Res Treat 2004;36:303-7. DOI ScienceOn |
13 | Donoghue S, Baden HS, Lauder I, Sobolewski S, Pringle JH. Immunohistochemical localization of caspase-3 correlates with clinical outcome in B-cell diffue-cell lymphoma. Cancer Res 1999;59:5386-91. PUBMED |
14 | Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306. DOI PUBMED ScienceOn |
15 | Garte SJ. The c-myc oncogene in tumor progression. Crit Rev Oncog 1993;4:435-49. PUBMED |
16 | Tanaka F, Kawano Y, Li M, et al. Prognostic significance of apoptotic index in completely resected non-small cell lung cancer. J Clin Oncol 1999;17:2728-36. DOI PUBMED |
17 | Nakagawara A, Nakamura Y, Ikeda H, et al. High levels of expression and nuclear localization of interleukin-1beta converting enzyme (ICE) and CPP32beta gene into malignant gliomas in vitro and in vivo. Cancer Res 1998;58:962-7. PUBMED |
18 | Takata T, Tanaka F, Yamada T, et al. Clinical significance of caspase-3 expression in pathologic-stage I non-small cell lung cancer. Int J Cancer 2001;96(suppl):54-60. |
19 | Gosney JR, Field JK, Gosney MA, et al. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types. Anticancer Res 1990;10:623-8. PUBMED |
20 | Glinsky GV, Glinsky VV, Ivanova AB, Hueser CJ. Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Letters 1998;115: 185-93. DOI ScienceOn |
21 | Krajewska M, Wang HG, Krajewski S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase-3), a cell death proteases. Cancer Res 1997;57: 1605-13. PUBMED |
22 | Volm M, Koomagi R, Mattern J, Efferth T. Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metastasis 2002;19:385-90. DOI ScienceOn |
23 | Koomagi R, Volm M. Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res 2000;20:493-6. DOI PUBMED ScienceOn |
24 | Volm M, Koomagi R. Prognostic relevance of c-myc and caspase-3 for patients with non-small cell lung cancer. Oncol Rep 2000;7:95-8. |
25 | Garte SJ. The c-myc oncogene in tumor progression. Crit Rev Oncog 1993;4:435-49. PUBMED |
![]() |